Dr Matthew Foxton is a consultant hepatologist at Chelsea and Westminster Hospital and King’s College Hospital in London.

This week, we’ve been voting for our favorite video in See the Real Thing, an imaginative campaign run by Hepatitis Australia aimed at stemming the tide of liver disease caused by the country’s leading viral cause of death, hep C.

The World Health Organization estimates that around 150 million people are infected with the hepatitis C virus.

Written by Debra Walters, www.heplikeme.com

I am a scientist and a research pharmacist.  I questioned everything when I began this treatment journey and I am glad I did.  The bad news is that the diagnosed Hepatitis C population is growing.  The good news is that pharmaceutical companies are investing in Hepatitis C research.

There has been more promising news on the treatment front with the announcement from the US Food and Drug Administration (FDA) that it has granted priority review to Gilead Sciences’ oral hepatitis C treatment sofosbuvir.

This week, we’re looking forward to VisualHepC, a unique exhibition that will allow artists and onlookers to explore the stigma and treatment of the virus through a range of original artwork.

We’ve been busy making the final preparations for the launch of our dedicated Hepatitis C News TV channel.

New figures from the World Health Organization (WHO) reveal that over 15 million adults are living with hepatitis C in the WHO European Region.

Fancy a meet and greet with Bruno Mars or Rod Stewart, a box set signed by Sting, or a guitar signed by artists Fun and Travis Barker?

The liver is a unique organ with its ability to repair itself by replicating cells, detoxify the body, synthesize protein and produce biochemical necessary for digestion.

Written by Larry Gibson. Larry lives in Palm Springs, California, with Dennis Golay, his partner of 32 years.  Born in Oklahoma, Larry worked as a fine finish carpenter for many years.  He currently works for an organization called AIDS Assistance Program which provides food assistance to low income HIV patients.